{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-008837","form_type":"8-K","ticker":"RGBP","cik":"0001589150","company_name":"Regen BioPharma Inc","filed_at":"2026-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.559315+00:00","generated_at":"2026-05-15T21:41:12.328414+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Regen Biopharma issues 77.85M shares to settle $68,723 in debt and fees","bullets":["Issued 77,849,847 common shares between Feb 4-27, 2026 for $53,474 principal, $4,249 interest, $11,000 fees.","Shares were issued in unregistered private placement under Section 4(a)(2) with no underwriter or commission.","Post-issuance outstanding shares total 212,318,424 as of March 3, 2026.","Implied issuance price of approximately $0.0009 per share, suggesting severe dilution for existing holders."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-008837","json":"https://secwatch.observer/filing/0001493152-26-008837.json","markdown":"https://secwatch.observer/filing/0001493152-26-008837.md","text":"https://secwatch.observer/filing/0001493152-26-008837.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1589150/000149315226008837/0001493152-26-008837-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1589150/000149315226008837/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T21:41:12.328414+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}